Insider Trading activities of Cardinal Health Inc insiders. , Part 2

Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Cardinal Health Inc since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Cardinal Health Inc since year 2005. (See page 1 of this report.) Table 2 shows the detailed insider transactions of Cardinal Health Inc since 2005. The reporting company's ticker symbol is CAH. The reporting company's CIK number is 721371.
The total value of stock buying since 2005 is $1,293,399.
The total value of stock sales since 2005 is $397,384,997.
The total value of stock option exercises since 2005 is $223,208,387.


 1   2 

Table 2. Detailed insider stock purchases, sales, and option exercises of Cardinal Health Inc insiders (CAH) , Part 2
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2013-05-06 Spaulding Jean G (Director) Option Ex 10,447 40.86 426,895
2013-05-06 Notebaert Richard C (Director) Sale 5,001 46.25 231,296
2013-05-06 Notebaert Richard C (Director) Option Ex 5,001 43.21 216,093
2013-01-23 Kaufmann Michael C (CEO, Pharmaceutical Segment) Sale 58,362 44.95 2,623,371
2013-01-23 Kaufmann Michael C (CEO, Pharmaceutical Segment) Option Ex 55,158 27.29 1,505,261
2013-01-23 Stephen Falk T (EVP, Gen. Counsel & Corp. Sec.) Sale 39,080 45.00 1,758,600
2013-01-23 Stephen Falk T (EVP, Gen. Counsel & Corp. Sec.) Option Ex 49,965 27.29 1,363,544
2013-01-23 Morford Craig S (Chief Legal/Compliance Officer) Sale 47,274 45.00 2,127,330
2013-01-23 Morford Craig S (Chief Legal/Compliance Officer) Option Ex 60,441 27.29 1,649,434
2013-01-14 Watkins Carole S (Chief HR Officer) Option Ex 643 22.90 14,724
2013-01-10 Blake Mark R (EVP - Strategy & Corp. Dev.) Sale 1,471 42.92 63,135
2013-01-10 Stephen Falk T (EVP, Gen. Counsel & Corp. Sec.) Sale 39,867 43.00 1,714,281
2013-01-10 Stephen Falk T (EVP, Gen. Counsel & Corp. Sec.) Option Ex 49,965 27.29 1,363,544
2012-12-14 Blake Mark R (EVP - Strategy & Corp. Dev.) Sale 2,330 42.25 98,442
2012-11-01 Laws Stuart G (SVP & Chief Accounting Officer) Sale 2,564 41.22 105,688
2012-10-04 Henderson Jeffrey William (Chief Financial Officer) Sale 46,226 40.00 1,849,040
2012-10-04 Henderson Jeffrey William (Chief Financial Officer) Option Ex 50,000 27.29 1,364,500
2012-09-10 Henderson Jeffrey William (Chief Financial Officer) Sale 77,081 38.29 2,951,431
2012-09-10 Henderson Jeffrey William (Chief Financial Officer) Option Ex 50,000 27.29 1,364,500
2012-09-07 Henderson Jeffrey William (Chief Financial Officer) Sale 2,329 39.39 91,739
2012-05-17 Spaulding Jean G (Director) Sale 8,135 42.06 342,158
2012-05-17 Spaulding Jean G (Director) Option Ex 9,801 28.80 282,268
2012-02-27 Lynch Michael A (CEO, Medical Segment) Sale 31,373 42.00 1,317,666
2012-02-27 Lynch Michael A (CEO, Medical Segment) Option Ex 39,400 27.29 1,075,226
2012-02-24 Lynch Michael A (CEO, Medical Segment) Sale 40,173 41.59 1,670,795
2012-02-24 Lynch Michael A (CEO, Medical Segment) Option Ex 32,173 27.61 888,457
2011-10-27 Kaufmann Michael C (CEO, Pharmaceutical Segment) Sale 41,164 44.95 1,850,321
2011-10-27 Kaufmann Michael C (CEO, Pharmaceutical Segment) Option Ex 53,158 27.29 1,450,681
2011-10-26 Kaufmann Michael C (CEO, Pharmaceutical Segment) Sale 2,000 44.95 89,900
2011-10-26 Kaufmann Michael C (CEO, Pharmaceutical Segment) Option Ex 2,000 27.29 54,580
2011-10-19 Laws Stuart G (SVP & Chief Accounting Officer) Sale 1,341 42.40 56,858
2011-09-14 Laws Stuart G (SVP & Chief Accounting Officer) Sale 1,191 41.14 48,997
2011-08-17 Laws Stuart G (SVP & Chief Accounting Officer) Sale 1,100 41.73 45,903
2011-07-13 Laws Stuart G (SVP & Chief Accounting Officer) Sale 1,100 46.68 51,348
2011-07-07 Stephen Falk T (EVP, Gen. Counsel & Corp. Sec.) Sale 11,121 47.00 522,687
2011-07-07 Stephen Falk T (EVP, Gen. Counsel & Corp. Sec.) Option Ex 13,617 27.61 376,033
2011-07-06 Finn John F (Director) Sale 2,864 46.50 133,176
2011-07-01 Kaufmann Michael C (CEO, Pharmaceutical Segment) Sale 10,143 45.95 466,070
2011-07-01 Kaufmann Michael C (CEO, Pharmaceutical Segment) Option Ex 10,143 32.33 327,923
2011-07-01 Watkins Carole S (Chief HR Officer) Sale 6,698 46.00 308,108
2011-07-01 Watkins Carole S (Chief HR Officer) Option Ex 9,276 22.90 212,420
2011-06-15 Laws Stuart G (SVP & Chief Accounting Officer) Sale 1,100 43.79 48,169
2011-05-19 Henderson Jeffrey William (Chief Financial Officer) Sale 57,854 45.25 2,617,893
2011-05-19 Henderson Jeffrey William (Chief Financial Officer) Option Ex 47,304 39.68 1,877,022
2011-05-11 Laws Stuart G (SVP & Chief Accounting Officer) Sale 1,025 44.96 46,084
2011-05-05 Kaufmann Michael C (CEO, Pharmaceutical Segment) Sale 10,143 44.95 455,927
2011-05-05 Kaufmann Michael C (CEO, Pharmaceutical Segment) Option Ex 10,143 32.33 327,923
2011-05-05 Stephen Falk T (EVP, Gen. Counsel & Corp. Sec.) Sale 6,954 45.00 312,930
2011-05-05 Stephen Falk T (EVP, Gen. Counsel & Corp. Sec.) Option Ex 3,437 22.90 78,707
2011-04-27 Kaufmann Michael C (CEO, Pharmaceutical Segment) Sale 10,143 43.95 445,784
2011-04-27 Kaufmann Michael C (CEO, Pharmaceutical Segment) Option Ex 10,143 32.33 327,923
2011-04-26 Stephen Falk T (EVP, Gen. Counsel & Corp. Sec.) Sale 2,267 43.00 97,481
2011-04-26 Stephen Falk T (EVP, Gen. Counsel & Corp. Sec.) Option Ex 3,053 22.90 69,913
2011-04-26 Henderson Jeffrey William (Chief Financial Officer) Sale 59,035 43.00 2,538,505
2011-04-26 Henderson Jeffrey William (Chief Financial Officer) Option Ex 59,035 39.68 2,342,508
2011-04-21 Kaufmann Michael C (CEO, Pharmaceutical Segment) Sale 8,560 42.95 367,652
2011-03-18 Kaufmann Michael C (CEO, Pharmaceutical Segment) Sale 177 40.95 7,248
2011-03-18 Kaufmann Michael C (CEO, Pharmaceutical Segment) Option Ex 177 22.90 4,053
2011-02-07 Kaufmann Michael C (CEO, Pharmaceutical Segment) Sale 87,544 41.71 3,651,460
2011-02-07 Kaufmann Michael C (CEO, Pharmaceutical Segment) Option Ex 80,648 23.34 1,882,243
2010-12-03 Kaufmann Michael C (CEO, Pharmaceutical Segment) Sale 633 37.29 23,604
2009-08-20 Watkins Carole S (Chief HR Officer) Sale 13,181 34.67 456,985
2009-08-20 Watkins Carole S (Chief HR Officer) Option Ex 13,181 31.17 410,812
2009-08-20 Finn John F (Director) Sale 2,877 34.81 100,148
2009-08-20 Finn John F (Director) Option Ex 3,338 29.96 99,999
2009-08-20 Notebaert Richard C (Director) Sale 4,517 34.64 156,468
2009-08-20 Notebaert Richard C (Director) Option Ex 4,517 33.21 150,005
2008-10-06 Walter Robert D (Director) Option Ex 562,500 31.17 17,531,437
2008-02-19 Walter Robert D (Executive Director) Option Ex 135,000 43.14 5,823,900
2008-02-15 Walter Robert D (Executive Director) Option Ex 312,500 31.17 9,739,687
2007-11-26 Walter Robert D (Executive Director) Option Ex 96,402 36.31 3,500,067
2007-11-26 Clark R Kerry (Chairman and CEO) Buy 20,000 57.49 1,149,860
2007-11-14 Walter Matthew D (Director) Sale 90,000 60.05 5,399,263
2007-10-15 Finn John F (Director) Option Ex 3,005 33.28 100,006
2007-06-04 Slusser Eric (EVP, CAO & Controller) Sale 19,600 72.77 1,426,292
2007-06-04 Slusser Eric (EVP, CAO & Controller) Option Ex 19,600 57.93 1,135,428
2007-06-04 Walter Robert D (Exec. Chairman of the Board) Option Ex 550,000 31.17 17,141,850
2007-06-04 Walter Matthew D (Director) Sale 6,997 72.73 508,891
2007-04-20 Watkins Carole S (Chief HR Officer) Sale 5,623 75.00 421,725
2007-04-20 Watkins Carole S (Chief HR Officer) Option Ex 5,623 39.72 223,362
2007-04-02 Schlotterbeck David L (CEO - Pharm & Med Products) Sale 375 73.00 27,375
2007-03-01 Spaulding Jean G (Director) Sale 485 70.21 34,051
2007-02-13 Gerbig Robert L (Director) Sale 6,343 72.16 457,691
2007-02-12 Gerbig Robert L (Director) Option Ex 6,343 31.62 200,559
2007-02-12 Mccoy John B (Director) Sale 3,005 70.78 212,693
2007-02-12 Mccoy John B (Director) Option Ex 3,005 33.28 100,006
2007-01-25 Walter Matthew D (Director) Sale 25,000 72.50 1,812,500
2006-12-27 Walter Robert D (Exec. Chairman of the Board) Option Ex 95,409 27.10 2,585,202
2006-12-15 Walter Robert D (Exec. Chairman of the Board) Sale 10,000 64.97 649,740
2006-12-15 Walter Robert D (Exec. Chairman of the Board) Option Ex 10,000 27.05 270,530
2006-12-14 Walter Robert D (Exec. Chairman of the Board) Sale 10,000 65.37 653,720
2006-12-14 Walter Robert D (Exec. Chairman of the Board) Option Ex 10,000 27.05 270,530
2006-12-13 Walter Robert D (Exec. Chairman of the Board) Sale 10,000 65.65 656,490
2006-12-13 Walter Robert D (Exec. Chairman of the Board) Option Ex 10,000 27.05 270,530
2006-12-12 Walter Robert D (Exec. Chairman of the Board) Sale 10,000 65.91 659,140
2006-12-12 Walter Robert D (Exec. Chairman of the Board) Option Ex 10,000 27.05 270,530
2006-12-11 Walter Robert D (Exec. Chairman of the Board) Sale 10,000 65.90 658,980
2006-12-11 Walter Robert D (Exec. Chairman of the Board) Option Ex 10,000 27.05 270,530
2006-12-11 Walter Matthew D (Director) Sale 90,000 65.90 5,931,270
2006-12-04 Walter Matthew D (Director) Sale 10,000 65.77 657,650
2006-09-14 Havens John F (Director) Option Ex 2,138 23.41 50,044
2006-08-30 Finn John F (Director) Option Ex 2,138 23.41 50,044
2006-08-21 Ford Brendan A (EVP-Corporate Development) Sale 1,500 67.61 101,422
2006-08-18 Ford Brendan A (EVP-Corporate Development) Sale 8,850 67.60 598,277
2006-08-18 Ford Brendan A (EVP-Corporate Development) Option Ex 10,350 27.05 279,998
2006-08-18 Schlotterbeck David L (CEO - Pharm & Med Products) Sale 20,000 67.51 1,350,200
2006-08-16 Gerbig Robert L (Director) Option Ex 2,138 23.41 50,044
2006-05-16 Watkins Carole S (EVP - Human Resources) Sale 175 68.01 11,901
2006-05-16 Labrum Ronald K (CEO-Supply Chain Svcs.) Sale 37,500 68.36 2,563,687
2006-05-16 Labrum Ronald K (CEO-Supply Chain Svcs.) Option Ex 37,500 31.17 1,168,762
2006-05-15 Walter Matthew D (Director) Sale 6,997 67.80 474,396
2006-05-11 Losh J Michael (Director) Option Ex 5,223 19.15 100,004
2006-05-11 Mccoy John B (Director) Option Ex 2,138 23.41 50,044
2006-02-01 Labrum Ronald K (CEO-Healthcare Suppl) Sale 19,554 72.10 1,409,882
2006-02-01 Labrum Ronald K (CEO-Healthcare Suppl) Option Ex 19,554 12.25 239,536
2006-01-31 Ford Brendan A (EVP-Corporate Develo) Option Ex 13,500 17.74 239,489
2005-09-12 Walter Robert D (Chairman and CEO) Sale 10,000 59.60 596,000
2005-08-10 Walter Robert D (Chairman and CEO) Sale 65,000 59.15 3,844,945
2005-07-11 Walter Robert D (Chairman and CEO) Sale 65,000 57.97 3,767,920
2005-06-10 Walter Robert D (Chairman and CEO) Sale 65,000 57.31 3,724,890
2005-04-11 Walter Robert D (Chairman and CEO) Sale 65,000 55.52 3,608,540
2005-03-10 Walter Robert D (Chairman and CEO) Sale 65,000 57.21 3,718,910
2003-01-15 Fotiades George L (President & COO) Buy 7 61.86 433
2002-10-15 Fotiades George L (President & COO) Buy 6 63.00 378
2002-07-15 Fotiades George L (President & COO) Buy 8 52.90 423
2002-04-15 Fotiades George L (President & COO) Buy 6 68.70 412
2002-01-15 Fotiades George L (President & COO) Buy 7 61.60 431
2001-10-15 Fotiades George L (President & COO) Buy 5 74.00 370
 1   2 

Insider trading activities including stock purchases, stock sales, and option exercises of CAH listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Cardinal Health Inc (symbol CAH, CIK number 721371) see the Securities and Exchange Commission (SEC) website.